Davide Bonazzi
Illustrator
From this contributor
Company on brink takes psilocybin to trial for fragile X syndrome
The phase 2A trial has its detractors despite positive animal results and is being sponsored by a company that is struggling financially.
Company on brink takes psilocybin to trial for fragile X syndrome
Explore more from The Transmitter
Insights on suicidality and autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 8 December.
Insights on suicidality and autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 8 December.
Exclusive: Springer Nature retracts, removes nearly 40 publications that trained neural networks on ‘bonkers’ dataset
The dataset contains images of children’s faces downloaded from websites about autism, which sparked concerns at Springer Nature about consent and reliability.
Exclusive: Springer Nature retracts, removes nearly 40 publications that trained neural networks on ‘bonkers’ dataset
The dataset contains images of children’s faces downloaded from websites about autism, which sparked concerns at Springer Nature about consent and reliability.
Seeing the world as animals do: How to leverage generative AI for ecological neuroscience
Generative artificial intelligence will offer a new way to see, simulate and hypothesize about how animals experience their worlds. In doing so, it could help bridge the long-standing gap between neural function and behavior.
Seeing the world as animals do: How to leverage generative AI for ecological neuroscience
Generative artificial intelligence will offer a new way to see, simulate and hypothesize about how animals experience their worlds. In doing so, it could help bridge the long-standing gap between neural function and behavior.